Table 3.

Proliferation (Ki‐67 LI) and telomerase subunit expression (hTERT LI) in vivo versus in vitro regarding the invasive confrontation pattern between our subgroups of intracranial tumours

WHO classification	Proliferation		hTERT
Invasion in vitro	In vivo	In vitro	In vivo	In vitro
Astrocytoma LG (n = 6)
Non‐invasive tumours	1.7 (SD = 1.6)	8.2 (SD = 7.0)	7.8 (SD = 4.3)	83.3 (SD = 21.0)
Invasive tumours	3.0 (SD = 2.8)	6.0 (SD = 1.5)	15.1 (SD = 16.3)	76.8 (SD = 28.0)
Glioblastoma multiforme (n = 8)
Non‐invasive tumours	23.1	17.8	5.0	95.2
Invasive tumours	22.2 (SD = 19.5)	18.0 (SD = 9.9)	41.0 (SD = 27.4)	91.0 (SD = 4.9)
Benign meningioma (n = 13)
Non‐invasive tumours	2.4 (SD = 2.9)	10.7 (SD = 8.0)	12.0 (SD = 20.1)	34.9 (SD = 38.2)
Invasive tumours	1.0 (SD = 0.8)	24.0 (SD = 24.0)	14.6 (SD = 19.0)	27.2 (SD = 36.8)